Over half of T2DM patients in primary care have MASLD; over 10% of those with obesity may have advanced fibrosis. Semaglutide improves liver health in MASH via weight loss and proteomic pathways, per a new Nature Medicine study. Pediatric male patients with nonalcoholic fatty liver disease (NAFLD) could benefit from a diet low in free sugars, ...